EIOPA Says Securitization Revival Needs Better Data and Products, Not Just Lower Capital Charges

Key Takeaways

• EIOPA argues that lower Solvency II capital charges for securitizations, effective January 2027, will not by themselves drive insurer investment, because product design, data quality, and asset-liability matching are the main constraints.
• It also warns that the proposed safeguards for unfunded credit protection in synthetic securitizations do not adequately address systemic and policyholder-protection risks.
• Compliance teams at insurers and banks should prepare for possible changes to the Securitisation Regulation while monitoring the trilogue outcome.

Deep Dive

EIOPA argues that lower Solvency II capital charges for securitizations, effective January 2027, will not by themselves drive insurer investment, because product design, data quality, and asset-liability matching are the main constraints. It also warns that the proposed safeguards for unfunded credit protection in synthetic securitizations do not adequately address systemic and policyholder-protection risks. Compliance teams at insurers and banks should prepare for possible changes to the Securitisation Regulation while monitoring the trilogue outcome.

The revised Solvency II framework takes effect in January 2027 and lowers capital requirements for securitization investments. EIOPA does not expect this alone to materially increase insurer participation. Its analysis found that risk-return profiles, asset-liability management, and complexity are the main drivers. Short duration, prepayment risk, fragmented issuance, limited liquidity, and the need for specialized expertise all weigh on investment. The standard formula changes also will not directly affect large insurers that use internal models. EIOPA stresses that simplified due diligence and transparency requirements must not weaken investors' ability to understand underlying exposures. It also says the STS label must not replace investors' own assessment or dilute originator responsibility. Reliable loan-level data, consistent definitions, and clear documentation are described as prerequisites for sound pricing and risk management.

The most sensitive issue is unfunded credit protection in synthetic securitizations. Broadening the pool of eligible providers could expand risk-sharing, but for insurers it creates a contingent liability that may crystallize in stressed credit conditions. EIOPA cites counterparty and concentration risk, greater bank-insurer interconnectedness, systemic risk, and policyholder harm, referencing monoline losses in the global financial crisis. It considers current safeguards inadequate. Insurers considering such protection should expect strong supervisory scrutiny, and EIOPA may push for tighter conditions in the final text. No specific compliance deadlines apply beyond the January 2027 Solvency II date, and the trilogue timeline remains open.

Recommended actions:

(1) track trilogue developments, especially on synthetic securitization, due diligence, transparency, risk retention, and STS provisions;

(2) review investment policies, the prudent person principle, and ORSA scenarios for securitization and contingent-liability exposures;

(3) assess the effect of the revised standard formula on capital planning, and, for internal model users, confirm whether any model changes are needed;

(4) strengthen data governance and independent due diligence so reliance on STS labels or originator information is not excessive;

(5) stress-test counterparty and concentration risk, including bank-insurer linkages; and

(6) engage with supervisors and industry bodies ahead of the final calibration.

Overall impact is moderate and primarily forward-looking. The main risks are regulatory uncertainty, potential supervisory pushback on synthetic risk-transfer activity, and weak governance if capital relief leads firms to invest in securitizations without adequate due diligence. Firms should avoid making investment decisions driven solely by prudential differences, as EIOPA explicitly cautions against such incentives.

Source: European Insurance and Occupational Pensions Authority